Vivani Medical
(NASDAQ) VANI
Vivani Medical Financials at a Glance
Market Cap
$99.17M
Revenue (TTM)
$0.00
Net Income (TTM)
-$27.09M
EPS (TTM)
-$0.40
P/E Ratio
-2.85
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$1.16
Volume
1,424
Open
$1.17
Price
$1.16
Volume
1,424
Open
$1.17
Previous Close
$1.16
Daily Range
$1.16 - $1.17
52-Week Range
$0.92 - $1.92
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
0.96 (Low)
Price
$1.16
Volume
1,424
Open
$1.17
Previous Close
$1.16
Daily Range
$1.16 - $1.17
52-Week Range
$0.92 - $1.92
Estimated Earnings Date
Aug 13, 2026
VANI News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vivani Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
42
CEO
Adam Mendelsohn, PhD
Website
www.vivani.comHeadquarters
Alameda, CA 94608, US
VANI Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-176%
Return on Capital
-78%
Return on Assets
-64%
Earnings Yield
-35.09%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$99.17M
Shares Outstanding
86.24M
Volume
1.42K
Avg. Volume
240.01K
Financials (TTM)
Gross Profit
-$424.00K
Operating Income
-$27.56M
EBITDA
-$26.19M
Operating Cash Flow
-$24.32M
Capital Expenditure
-$1.17M
Free Cash Flow
-$25.49M
Cash & ST Invst.
$16.23M
Total Debt
$18.86M
Vivani Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$130.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$99.17M
N/A
Market Cap/Employee
$2.68M
N/A
Employees
37
N/A
Net Income
-$6.78M
-7.6%
EBITDA
-$6.65M
-7.3%
Quarterly Fundamentals
Total Cash
$19.75M
+51.8%
Total Debt
$18.28M
-3.5%
Accounts Receivable
$12.00K
-93.1%
Inventory
$0.00
N/A
Long Term Debt
$16.49M
-6.4%
Short Term Debt
$1.78M
+35.9%
Return on Assets
-63.96%
N/A
Return on Invested Capital
-78.18%
N/A
Free Cash Flow
-$6.20M
-19.9%
Operating Cash Flow
-$6.20M
-20.0%